Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Situation Analysis of the Capacity of Laboratories in Faith-Based Hospitals in Zambia to Conduct Surveillance of Antimicrobial Resistance: Opportunities to Improve Diagnostic Stewardship.
Shempela DM, Mudenda S, Kasanga M, Daka V, Kangongwe MH, Kamayani M, Sikalima J, Yankonde B, Kasonde CB, Nakazwe R, Mwandila A, Cham F, Njuguna M, Simwaka B, Morrison L, Chizimu JY, Muma JB, Chilengi R, Sichinga K. Shempela DM, et al. Among authors: cham f. Microorganisms. 2024 Aug 17;12(8):1697. doi: 10.3390/microorganisms12081697. Microorganisms. 2024. PMID: 39203539 Free PMC article.
Wastewater Surveillance of SARS-CoV-2 in Zambia: An Early Warning Tool.
Shempela DM, Muleya W, Mudenda S, Daka V, Sikalima J, Kamayani M, Sandala D, Chipango C, Muzala K, Musonda K, Chizimu JY, Mulenga C, Kapona O, Kwenda G, Kasanga M, Njuguna M, Cham F, Simwaka B, Morrison L, Muma JB, Saasa N, Sichinga K, Simulundu E, Chilengi R. Shempela DM, et al. Among authors: cham f. Int J Mol Sci. 2024 Aug 14;25(16):8839. doi: 10.3390/ijms25168839. Int J Mol Sci. 2024. PMID: 39201525 Free PMC article.
Detection and Characterisation of SARS-CoV-2 in Eastern Province of Zambia: A Retrospective Genomic Surveillance Study.
Shempela DM, Chambaro HM, Sikalima J, Cham F, Njuguna M, Morrison L, Mudenda S, Chanda D, Kasanga M, Daka V, Kwenda G, Musonda K, Munsaka S, Chilengi R, Sichinga K, Simulundu E. Shempela DM, et al. Among authors: cham f. Int J Mol Sci. 2024 Jun 7;25(12):6338. doi: 10.3390/ijms25126338. Int J Mol Sci. 2024. PMID: 38928045 Free PMC article.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
Happe M, Hofstetter AR, Wang J, Yamshchikov GV, Holman LA, Novik L, Strom L, Kiweewa F, Wakabi S, Millard M, Kelley CF, Kabbani S, Edupuganti S, Beck A, Kaltovich F, Murray T, Tsukerman S, Carr D, Ashman C, Stanley DA, Ploquin A, Bailer RT, Schwartz R, Cham F, Tindikahwa A, Hu Z, Gordon IJ, Rouphael N, Houser KV, Coates EE, Graham BS, Koup RA, Mascola JR, Sullivan NJ, Robb ML, Ake JA, Lyke KE, Mulligan MJ, Ledgerwood JE, Kibuuka H; VRC 208 and RV 422 study team. Happe M, et al. Among authors: cham f. NPJ Vaccines. 2024 Mar 29;9(1):67. doi: 10.1038/s41541-024-00833-z. NPJ Vaccines. 2024. PMID: 38553525 Free PMC article.
An Integrated Sample Referral System for HIV Viral Load and Early Infant Diagnosis in North-Western Province, Zambia-A Retrospective Cross-Sectional Study.
Shempela DM, Sikalima J, Mwandia J, Mwila E, Chilyabanyama R, Masona M, Kasonde CB, Mwandila A, Kamalamba H, Kasanga M, Mutanekelwa I, Mudenda S, Kandama FJ, Cham F, Njuguna M, McCarrick P, Morrison L, Daka V, Sichinga K. Shempela DM, et al. Among authors: cham f. Healthcare (Basel). 2024 Mar 8;12(6):618. doi: 10.3390/healthcare12060618. Healthcare (Basel). 2024. PMID: 38540582 Free PMC article.
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion.
Olwenyi OA, Asingura B, Naluyima P, Anywar GU, Nalunga J, Nakabuye M, Semwogerere M, Bagaya B, Cham F, Tindikahwa A, Kiweewa F, Lichter EZ, Podany AT, Fletcher CV, Byrareddy SN, Kibuuka H. Olwenyi OA, et al. Among authors: cham f. BMC Complement Med Ther. 2021 Apr 9;21(1):114. doi: 10.1186/s12906-021-03288-0. BMC Complement Med Ther. 2021. PMID: 33836748 Free PMC article.
Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
Fokam J, Takou D, Njume D, Pabo W, Santoro MM, Njom Nlend AE, Beloumou G, Sosso S, Moudourou S, Teto G, Dambaya B, Djupsa S, Tetang Ndiang S, Ateba FN, Billong SC, Kamta C, Bala L, Lambo V, Tala V, Chenwi Ambe C, Mpouel ML, Cappelli G, Cham F, Ndip R, Mbuagbaw L, Koki Ndombo P, Ceccherini-Silberstein F, Colizzi V, Perno CF, Ndjolo A. Fokam J, et al. Among authors: cham f. HIV Med. 2021 Aug;22(7):567-580. doi: 10.1111/hiv.13095. Epub 2021 Mar 31. HIV Med. 2021. PMID: 33792134 Free article.
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens.
Fokam J, Takou D, Semengue ENJ, Teto G, Beloumou G, Dambaya B, Santoro MM, Mossiang L, Billong SC, Cham F, Sosso SM, Temgoua ES, Nanfack AJ, Moudourou S, Kamgaing N, Kamgaing R, Ngako Pamen JN, Etame MMN, Bissek AZ, Elat JN, Moussi EE, Colizzi V, Perno CF, Ndjolo A; VIROFORUM. Fokam J, et al. Among authors: cham f. Antimicrob Resist Infect Control. 2020 Aug 26;9(1):143. doi: 10.1186/s13756-020-00799-2. Antimicrob Resist Infect Control. 2020. PMID: 32843050 Free PMC article.
Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low-income and middle-income countries.
Inzaule SC, Jordan MR, Cournil A, Girón-Callejas A, Avila-Rios S, Mulenga L, Ssemwanga D, Asio J, Diop-Ndiaye H, Niasse-Traore F, Nhan DT, Dat VQ, Aghokeng AF, Billong S, Cham F, Doherty M, Bertagnolio S; Acquired HIV Drug Resistance Survey Team. Inzaule SC, et al. Among authors: cham f. AIDS. 2020 Nov 1;34(13):1965-1969. doi: 10.1097/QAD.0000000000002623. AIDS. 2020. PMID: 32694410
33 results